Antivirals Market Analysis Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Antivirals Market
Antivirals Market Analysis: By Type (Hepatitis-C, HIV, Herpes, Hepatitis-B, Influenza & Other Antivirals); By Action (DNA polymerase inhibitors, NS3 Protease inhibitors, Reverse transcriptase inhibitors and Others) – With Forecast (2018-2023)
Report Code : HCR 0130
Updated Date: 08 March, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Antivirals– Market Overview
2. Executive Summary 
3. Antivirals– Market Landscape 
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Antivirals– Market Forces
   4.1. Market Drivers 
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Antivirals Market 
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers 
      4.4.3. Threat of New Entrants 
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Antivirals Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis 
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Antivirals Market– By Type
   6.1. Hepatitis-C antivirals
   6.2. HIV antivirals
   6.3. Herpes antivirals
   6.4. Hepatitis-B antivirals
   6.5. Influenza antivirals
   6.6. Others
7. Antivirals Market– By Actions
   7.1. DNA polymerase inhibitors
   7.2. NS3 Protease inhibitors
   7.3. Reverse transcriptase inhibitors 
   7.4. Others
8. Antivirals Market– By Geography
   8.1. Introduction
   8.2. Global Study
   8.3. Americas
      8.3.1. North America 
      8.3.2. Brazil
      8.3.3. Argentina
      8.3.4. Others 
   8.4. Europe
      8.4.1. U.K.
      8.4.2. France
      8.4.3. Germany
      8.4.4. Others
   8.5. APAC
      8.5.1. China
      8.5.2. Japan
      8.5.3. India
      8.5.4. Others
   8.6. ROW
9. Antivirals Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles 
   10.1. Novartis AG
   10.2. Gilead Sciences Inc.
   10.3. Merck
   10.4. Johnson and Johnson
   10.5. GlaxoSmithKline
   10.6. Abbott Laboratories
   10.7. AstraZeneca AB
   10.8. BoehringerIngelheim Corporation
   10.9. Schering-Plough
   10.10. Roche
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Antivirals are drugs that are used to treat viral infections. While a majority of antivirals are used for treating specific viral infections, there are a few broad-spectrum antivirals to treat other viral infections. As opposed to antibiotics that actually destroy the target pathogen, antivirals only inhibit the growth of the pathogen. Antivirals have the advantage of not causing any side effects and focus on inibiting the replication of the virus. An increase in the disease afflicted population across the globe is one of the major drivers for this market. Apart from this, increasing levels of awareness coupled with the launch of newer and more effective drugs, this market has tremendous opportunities in emerging economies. The antiviral market is expected to grow at a steady and healthy growth rate till the end of the forecast period considered in this report.  Expiry of patents is another factor providing opportunities for this market. Factors that include government policies can prove to be challenges in this market. 

The report also provides an exhaustive overview of antiviral research and development pipeline. A huge amount of research and development is underway to extend the range of antivirals to treat other pathogens. Also, with the tendency of viruses to mutate and become drug resistant, the need of the hour is to develop and refresh the pipeline of antivirals with new therapies.  A section on patent analysis is also included. 

Antivirals Market
 

Antiviral drugs are used in the treatment of  HIV, herpes viruses, the hepatitis B and C viruses, and influenza A and B viruses. The global antivirals market is expected to be dominated by HIV antivirals. According to the WHO and UNAIDS estimates, 36.7 million people were living with HIV globally at the end of 2015. In 2015, approximately 2.1 million people became newly infected and 1.1 million died of HIV-related causes. 

The Antivirals market can be segmented on the basis of type as:
  • HIV Antivirals
  • Hepatitis-C Antivirals
  • Herpes Antivirals
  • Influenza Antivirals
  • Hepatitis-B Antivirals
  • Other Antivirals 

In terms of actions, the Antivirals market has been segmented across the following:
  • DNA polymerase inhibitors
  • NS3 Protease inhibitors
  • Reverse transcriptase inhibitors 
The market has been segmented based on the following geographies:
  • North America
  • South America
  • APAC
  • Europe
  • Middle East 
  • Africa

Sample Companies Profiled in this Report are: 
  • GlaxoSmithKline plc
  • Merck & Co
  • Johnson and Johnson
  • Novartis International AG
  • Gilead Sciences Inc
  • 10+
List of Tables

Table1: Antivirals Market Overview 2017-2023
Table2: Antivirals Market Leader Analysis 2017-2018 (US$)
Table3: Antivirals Market Product Analysis 2017-2018 (US$)
Table4: Antivirals Market End User Analysis 2017-2018 (US$)
Table5: Antivirals Market Patent Analysis 2013-2018* (US$)
Table6: Antivirals Market Financial Analysis 2017-2018 (US$)
Table7: Antivirals Market Driver Analysis 2017-2018 (US$)
Table8: Antivirals Market Challenges Analysis 2017-2018 (US$)
Table9: Antivirals Market Constraint Analysis 2017-2018 (US$)
Table10: Antivirals Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table11: Antivirals Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table12: Antivirals Market Threat of Substitutes Analysis 2017-2018 (US$)
Table13: Antivirals Market Threat of New Entrants Analysis 2017-2018 (US$)
Table14: Antivirals Market Degree of Competition Analysis 2017-2018 (US$)
Table15: Antivirals Market Value Chain Analysis 2017-2018 (US$)
Table16: Antivirals Market Pricing Analysis 2018-2023 (US$)
Table17: Antivirals Market Opportunities Analysis 2018-2023 (US$)
Table18: Antivirals Market Product Life Cycle Analysis 2018-2023 (US$)
Table19: Antivirals Market Supplier Analysis 2017-2018 (US$)
Table20: Antivirals Market Distributor Analysis 2017-2018 (US$)
Table21: Antivirals Market Trend Analysis 2017-2018 (US$)
Table22: Antivirals Market Size 2017 (US$)
Table23: Antivirals Market Forecast Analysis 2018-2023 (US$)
Table24: Antivirals Market Sales Forecast Analysis 2018-2023 (Units)
Table25: Antivirals Market, Revenue & Volume,By Type, 2018-2023 ($)
Table26: Antivirals Market By Type, Revenue & Volume,By Hepatitis-C antivirals, 2018-2023 ($)
Table27: Antivirals Market By Type, Revenue & Volume,By HIV antivirals, 2018-2023 ($)
Table28: Antivirals Market By Type, Revenue & Volume,By Herpes antivirals, 2018-2023 ($)
Table29: Antivirals Market By Type, Revenue & Volume,By Hepatitis-B antivirals, 2018-2023 ($)
Table30: Antivirals Market By Type, Revenue & Volume,By Influenza antivirals, 2018-2023 ($)
Table31: Antivirals Market, Revenue & Volume,By Actions, 2018-2023 ($)
Table32: Antivirals Market By Actions, Revenue & Volume,By DNA polymerase inhibitors, 2018-2023 ($)
Table33: Antivirals Market By Actions, Revenue & Volume,By NS3 Protease inhibitors, 2018-2023 ($)
Table34: Antivirals Market By Actions, Revenue & Volume,By Reverse transcriptase inhibitors, 2018-2023 ($)
Table55: North America Antivirals Market, Revenue & Volume,By Type, 2018-2023 ($)
Table56: North America Antivirals Market, Revenue & Volume,By Actions, 2018-2023 ($)
Table60: South america Antivirals Market, Revenue & Volume,By Type, 2018-2023 ($)
Table61: South america Antivirals Market, Revenue & Volume,By Actions, 2018-2023 ($)
Table65: Europe Antivirals Market, Revenue & Volume,By Type, 2018-2023 ($)
Table66: Europe Antivirals Market, Revenue & Volume,By Actions, 2018-2023 ($)
Table70: APAC Antivirals Market, Revenue & Volume,By Type, 2018-2023 ($)
Table71: APAC Antivirals Market, Revenue & Volume,By Actions, 2018-2023 ($)
Table75: Middle East & Africa Antivirals Market, Revenue & Volume,By Type, 2018-2023 ($)
Table76: Middle East & Africa Antivirals Market, Revenue & Volume,By Actions, 2018-2023 ($)
Table80: Russia Antivirals Market, Revenue & Volume,By Type, 2018-2023 ($)
Table81: Russia Antivirals Market, Revenue & Volume,By Actions, 2018-2023 ($)
Table85: Israel Antivirals Market, Revenue & Volume,By Type, 2018-2023 ($)
Table86: Israel Antivirals Market, Revenue & Volume,By Actions, 2018-2023 ($)
Table90: Top Companies 2017 (US$)Antivirals Market, Revenue & Volume
Table91: Product Launch 2017-2018Antivirals Market, Revenue & Volume
Table92: Mergers & Acquistions 2017-2018Antivirals Market, Revenue & Volume


List of Figures

Figure 1: Overview of Antivirals Market 2017-2023
Figure 2: Market Share Analysis for Antivirals Market 2017 (US$)
Figure 3: Product Comparison in Antivirals Market 2017-2018 (US$)
Figure 4: End User Profile for Antivirals Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Antivirals Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Antivirals Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Antivirals Market 2017-2018
Figure 8: Ecosystem Analysis in Antivirals Market 2017
Figure 9: Average Selling Price in Antivirals Market 2017-2023
Figure 10: Top Opportunites in Antivirals Market 2017-2018
Figure 11: Market Life Cycle Analysis in Antivirals Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy TypeAntivirals Market Revenue, 2018-2023 ($)
Figure 13: GlobalBy ActionsAntivirals Market Revenue, 2018-2023 ($)
Figure 17: Global Antivirals Market - By Geography
Figure 18: Global Antivirals Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 19: Global Antivirals Market CAGR, By Geography, 2018-2023 (%)
Figure 20: North America Antivirals Market Value & Volume, 2018-2023 ($)
Figure 21: US Antivirals Market Value & Volume, 2018-2023 ($)
Figure 22: US GDP and Population, 2017-2018 ($)
Figure 23: US GDP – Composition of 2017, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2017-2018 ($)
Figure 25: Canada Antivirals Market Value & Volume, 2018-2023 ($)
Figure 26: Canada GDP and Population, 2017-2018 ($)
Figure 27: Canada GDP – Composition of 2017, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 29: Mexico Antivirals Market Value & Volume, 2018-2023 ($)
Figure 30: Mexico GDP and Population, 2017-2018 ($)
Figure 31: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 33: South America Antivirals Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 34: Brazil Antivirals Market Value & Volume, 2018-2023 ($)
Figure 35: Brazil GDP and Population, 2017-2018 ($)
Figure 36: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 38: Venezuela Antivirals Market Value & Volume, 2018-2023 ($)
Figure 39: Venezuela GDP and Population, 2017-2018 ($)
Figure 40: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 42: Argentina Antivirals Market Value & Volume, 2018-2023 ($)
Figure 43: Argentina GDP and Population, 2017-2018 ($)
Figure 44: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 46: Ecuador Antivirals Market Value & Volume, 2018-2023 ($)
Figure 47: Ecuador GDP and Population, 2017-2018 ($)
Figure 48: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 50: Peru Antivirals Market Value & Volume, 2018-2023 ($)
Figure 51: Peru GDP and Population, 2017-2018 ($)
Figure 52: Peru GDP – Composition of 2017, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 54: Colombia Antivirals Market Value & Volume, 2018-2023 ($)
Figure 55: Colombia GDP and Population, 2017-2018 ($)
Figure 56: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 58: Costa Rica Antivirals Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 59: Costa Rica GDP and Population, 2017-2018 ($)
Figure 60: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 62: Europe Antivirals Market Value & Volume, 2018-2023 ($)
Figure 63: U.K Antivirals Market Value & Volume, 2018-2023 ($)
Figure 64: U.K GDP and Population, 2017-2018 ($)
Figure 65: U.K GDP – Composition of 2017, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 67: Germany Antivirals Market Value & Volume, 2018-2023 ($)
Figure 68: Germany GDP and Population, 2017-2018 ($)
Figure 69: Germany GDP – Composition of 2017, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 71: Italy Antivirals Market Value & Volume, 2018-2023 ($)
Figure 72: Italy GDP and Population, 2017-2018 ($)
Figure 73: Italy GDP – Composition of 2017, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 75: France Antivirals Market Value & Volume, 2018-2023 ($)
Figure 76: France GDP and Population, 2017-2018 ($)
Figure 77: France GDP – Composition of 2017, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2017-2018 ($)
Figure 79: Netherlands Antivirals Market Value & Volume, 2018-2023 ($)
Figure 80: Netherlands GDP and Population, 2017-2018 ($)
Figure 81: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 83: Belgium Antivirals Market Value & Volume, 2018-2023 ($)
Figure 84: Belgium GDP and Population, 2017-2018 ($)
Figure 85: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 87: Spain Antivirals Market Value & Volume, 2018-2023 ($)
Figure 88: Spain GDP and Population, 2017-2018 ($)
Figure 89: Spain GDP – Composition of 2017, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 91: Denmark Antivirals Market Value & Volume, 2018-2023 ($)
Figure 92: Denmark GDP and Population, 2017-2018 ($)
Figure 93: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 95: APAC Antivirals Market Value & Volume, 2018-2023 ($)
Figure 96: China Antivirals Market Value & Volume, 2018-2023
Figure 97: China GDP and Population, 2017-2018 ($)
Figure 98: China GDP – Composition of 2017, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2017-2018 ($)Antivirals Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 100: Australia Antivirals Market Value & Volume, 2018-2023 ($)
Figure 101: Australia GDP and Population, 2017-2018 ($)
Figure 102: Australia GDP – Composition of 2017, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 104: South Korea Antivirals Market Value & Volume, 2018-2023 ($)
Figure 105: South Korea GDP and Population, 2017-2018 ($)
Figure 106: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 108: India Antivirals Market Value & Volume, 2018-2023 ($)
Figure 109: India GDP and Population, 2017-2018 ($)
Figure 110: India GDP – Composition of 2017, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2017-2018 ($)
Figure 112: Taiwan Antivirals Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 113: Taiwan GDP and Population, 2017-2018 ($)
Figure 114: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 116: Malaysia Antivirals Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 117: Malaysia GDP and Population, 2017-2018 ($)
Figure 118: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 120: Hong Kong Antivirals Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121: Hong Kong GDP and Population, 2017-2018 ($)
Figure 122: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 124: Middle East & Africa Antivirals Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 125: Russia Antivirals Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 126: Russia GDP and Population, 2017-2018 ($)
Figure 127: Russia GDP – Composition of 2017, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 129: Israel Antivirals Market Value & Volume, 2018-2023 ($)
Figure 130: Israel GDP and Population, 2017-2018 ($)
Figure 131: Israel GDP – Composition of 2017, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 133: Entropy Share, By Strategies, 2017-2018* (%)Antivirals Market 
Figure 134: Developments, 2017-2018*Antivirals Market 
Figure 135: Company 1 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 136: Company 1 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 137: Company 1 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 138: Company 2 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 139: Company 2 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 140: Company 2 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 141: Company 3Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 142: Company 3Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 143: Company 3Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 144: Company 4 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 145: Company 4 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 146: Company 4 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 147: Company 5 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 148: Company 5 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 149: Company 5 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 150: Company 6 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 151: Company 6 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 152: Company 6 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 153: Company 7 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 154: Company 7 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 155: Company 7 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 156: Company 8 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 157: Company 8 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 158: Company 8 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 159: Company 9 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 160: Company 9 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 161: Company 9 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 162: Company 10 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 163: Company 10 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 164: Company 10 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 165: Company 11 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 166: Company 11 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 167: Company 11 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 168: Company 12 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 169: Company 12 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 170: Company 12 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 171: Company 13Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 172: Company 13Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 173: Company 13Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 174: Company 14 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 175: Company 14 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 176: Company 14 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Figure 177: Company 15 Antivirals Market Net Revenue, By Years, 2017-2018* ($)
Figure 178: Company 15 Antivirals Market Net Revenue Share, By Business segments, 2017 (%)
Figure 179: Company 15 Antivirals Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll